Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.110
-0.040 (-3.48%)
Jun 27, 2025, 4:08 PM HKT
105.56%
Market Cap 10.13B
Revenue (ttm) 2.02B
Net Income (ttm) -230.57M
Shares Out 9.13B
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend 0.02 (1.83%)
Ex-Dividend Date Sep 27, 2024
Volume 108,457,000
Average Volume 161,701,743
Open 1.150
Previous Close 1.150
Day's Range 1.100 - 1.160
52-Week Range 0.495 - 1.250
Beta 0.69
RSI 64.15
Earnings Date Aug 29, 2025

About HKG:0460

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China. The company operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. It offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solu... [Read more]

Sector Healthcare
Founded 2001
Employees 2,667
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0460
Full Company Profile

Financial Performance

In 2024, HKG:0460's revenue was 1.90 billion, an increase of 2.18% compared to the previous year's 1.86 billion. Losses were -216.66 million, 301.1% more than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.